Thursday, December 14, 2006

Transurethral Microwave Thermotherapy (TUMT) | MAC Jurisdiction 3 |

Transurethral Microwave Thermotherapy (TUMT) | MAC Jurisdiction 3 | "TUMT, an appropriate therapy for symptomatic benign prostatic hypertrophy (BPH), is a method of delivering microwave heating sufficient to destroy prostatic adenoma tissue without significant damage to surrounding tissue. The FDA has, on May 3, 1996, approved a device for delivering this microwave therapy. TUMT is another nonsurgical therapy for BPH, and is appropriate when the following indications are met.

All of the following characteristics must be present.
A. Bladder Outlet Obstruction (BOO) and Lower Urinary Tract Symptoms (LUTS) of significant degree to cause an American Urological Association Symptom Score above seven. A score from 0-7 reflects mild symptoms, from 8-19 moderate, and from 20-35 severe. A patient with mild symptoms may be treated with medicine or, appropriately, receive no treatment at all. A patient with moderate symptoms may be treated with medical or surgical procedures. Noridian leaves this decision to the physician and the patient.
B. A peak urine flow rate of 15 milliliters per second or less on a voided volume of 125 milliliters or greater.

Relative contraindications:
A. Prostate cancer
B. Neurogenic bladder
C. Active urinary tract infection
D. Active cystolithiasis
E. Gross hematuria
F. Urethral stricture
G. Bladder neck contracture
H. Acute prostatitis
I. Cardiac pacemaker

When present, active cystolithiasis or active infection should be treated prior to treatment with TUMT.

When prostate cancer and urinary obstruction are both present, TUMT may be appropriate therapy for relief of the urinary obstruction.

Absolute contraindication:
The presence of a metallic hip replacement."